Healthcare Blogs

  Antibody Drug Conjugate Market Analysis The global antibody drug conjugate (ADC) market is projected to witness a stupendous growth at a notable 16.70% CAGR over the predicted years. ADCs are made of three parts- first a specific antibody for binding, an antigen that has limited expression on the normal cells, second a cytotoxic agent to kill target cancer cells and third a chemical linker to attach the cytotoxic agent to the antibody. This is how antibody drug conjugates work. They are the new age of therapeutic agents. One of the key advantages of antibody drug conjugates is that this will help in bringing together the finest characteristics of both antibodies as well as the chemotherapy’s cytotoxic potential. There are many factors that is fuelling the growth of the antibody drug conjugate market . The different market trends and factors in this market according to an analysis performed by Market Research Future (MRFR) include increasing prevalence of cancer, advancement in me

  Medical Imaging Software Market Highlights Medical imaging software supports processing and producing high-resolution images of the internal body parts of a human for disease diagnosis and treatment. The emergence of 3D and 4D imaging technologies, increasing the prevalence of geriatric population and subsequent growth in the incidence of cardiac, and neurological diseases including cancer, growing government funding’s for development of medical diagnostics field are some factors that are anticipated to drive the market growth during the assessment period.  Additionally, a rise in the number of diagnostic centres and increased healthcare expenditure is likely to contribute to market growth. As per the data by the Office for National Statistics, in 2016, the gross domestic expenditure on research and development (R&D) was Euro 33.1 billion (USD 35.2 billion) in the UK. However, the high cost of equipment related to clinical validation and lack of skilled professionals may hamper

  Gene Editing Market Overview   The Global Gene Editing Market is growing with the rapid pace, mainly due to the technological advancement in the healthcare sector. According to a recent study report published by the Market Research Future, the global market of Gene Editing Market is booming and expected to gain prominence over the forecast period. The gene editing market value is expected to grow at a CAGR (Compound Annual Growth Rate) of about 14.7% to reach USD 19.4 billion over the forecast 2022-2030.    Global Market is driven by the Increased R&D expenditure and growth of biotechnology and pharmaceutical industries, increased funding for genomics research, increasing demand for synthetic genes, global rise in production of genetically modified crops and technological advancements. The restraints of the Gene Editing Market is strict regulatory policies and adverse public perception related to genetic research   Gene Editing or Genome editing is a type of genetic

  mHealth Market Highlights The wave of modernization in the healthcare sector has led to the penetration of the concept of mHealth greatly. Reports that gauge the healthcare IT industry has been made available by Market Research Future which creates reports on several industry verticals that review the market growth and prospects. MHealth Market Size was valued at USD 58.2 billion in 2022. The mHealth market industry is projected to grow from USD 64.8 Billion in 2023 to USD 123.1 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 11.30% during the forecast period (2023 - 2030). The robust growth pace in the wearable health device sector has increased the expansion of the mHealth market globally. Moreover, increased usage of smartphones is also playing a key role in the growth of the market. Also, patients are increasingly involved and aware of their treatments which is expected to further influence the mHealth market in the forecast period. Competitive Analys

  Human Insulin Market – Highlights Market Research Future (MRFR) expects the human insulin market to attain a 4.72% CAGR between 2022 and 2030. The market size could touch USD 2.55 Billion by 2030. Change in lifestyle and high prevalence of obesity is the root cause of widespread occurrence of diabetes which induces demand for human insulin. The rise in the global geriatric population who are at more risk of suffering from diabetes coupled with raising awareness of diabetes boosts the growth of the global human insulin market . Growing emphasis on diabetes management and technological advancement of insulin delivery devices such as the introduction of insulin pens have added fuel to ten growths of the market. The rise in several clinical trials for the development of novel therapies and treatment for diabetes purveyed by investment from pharmaceuticals companies has been a plus for the market growth. However, the soaring price of human insulin, manufacturing complexities and com

  Gastroparesis Treatment Market Highlights The drugs product type segment is expected to account for the maximum market share of the global Gastroparesis treatment market. Prokinetic medications that stimulate gastric emptying, including metoclopramide, erythromycin, and domperidone, lead the drug segment. Although Idiopathic Gastroparesis leads the market share the Diabetic Gastroparesis is the fastest growing segment. Gastric electric stimulation (GES) etc. will however grow at a faster level as compared to drug segment.   The Gastroparesis Treatment Market is anticipated to reach USD 7,768.31 million by 2030 at 3.20% CAGR during the forecast period 2022-2030 .   The product development strategy is the best when it comes to be the market leader. There is a need of novel drug with greater efficacy and low side effects. The device segment is the segment to watch as there will be greater growth and has a high potential for product development such as miniaturization. Lates

  Fabry Disease Treatment Market Highlights: Fabry disease market is expected to reach USD 3.55 billion by 2030 at CAGR of 7.8% over the figure period 2022-2030. Technological advancements, strong pipeline, advancements in healthcare facilities, and favourable funding policies are expected to drive the market growth over the forecast period. Owing to the increasing awareness about Fabry disease market new and existing market players are coming up with better treatment approaches. For instance, in 2018, 2018, Amicus Therapeutics launched Gala fold capsules 123mg for the treatment of patients aged 16 years and older with a confirmed diagnosis of Fabry disease and who have an amenable mutation. However, diverse range of symptoms, and related complications can restrain the market growth over the assessment period. Regional Analysis: Geographically, the Americas is expected to dominate the global market owing to the increasing technological advancements and rising research and deve